Sibling Oocyte Study of Medium for In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) With no Human Serum Albumine

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

PHASE2

Study Classification

INTERVENTIONAL

Study Start Date

2007-09-30

Study Completion Date

2014-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if a new medium with no human serum albumine added is as good as the media conventionally used for IVF/ICSI.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Fresh Vs Frozen Surgical Sperm in IVF

NCT03361982

Infertility

TERMINATED NA

Oocyte Cryopreservation: Evaluation of an Oocyte Freezing and Thawing Technique

NCT00713869

Infertility

UNKNOWN

Oocyte Cryopreservation by Slow Freezing and Vitrification

NCT01223105

Women Diagnosed With Cancer Egg Donors Single Women +1 more

TERMINATED PHASE2/PHASE3

Retrospective Database Studies

NCT01219296

All Patients Undergoing Infertility Treatment

COMPLETED

Prospective Sibling Oocyte Study of a New Method to Improve Embryo Development in IVF/ICSI Patients

NCT05680363

Infertility

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cells attained in IVF/ICSI procedures are kept in a medium that nurture the cells. Until now all such media have contained human serum albumine. The purpose of this study is to determine if a new medium with no human serum albumine added is as good as the media conventionally used for IVF/ICSI.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

In Vitro Fertilization Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Medium with no human serum albumine added

Group Type EXPERIMENTAL

Medium with no human serum albumine added

Intervention Type OTHER

See above

2

Conventional medium

Group Type ACTIVE_COMPARATOR

Conventional medium

Intervention Type OTHER

See above

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Medium with no human serum albumine added

See above

Intervention Type OTHER

Conventional medium

See above

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Couples seeking IVF/ICSI.
* Female under 38 years of age.
* No more than two previous IVF/ICSI treatments without pregnancy.
* Regular menstruation periods.
* No endocrine disease that requires treatment in the female.
* BMI below 30 in the female.
* At least 8 mature follicles upon monitoring or 6 MII oocytes upon ICSI.
* Written informed consent.